XM无法为美国居民提供服务。
G
G

GSK


市场新闻

WHO recommends maternal vaccine and antibody shot to prevent RSV in infants

UPDATE 1-WHO recommends maternal vaccine and antibody shot to prevent RSV in infants Adds comments from WHO press conference in paragraphs 7 to 10 By Kashish Tandon and Bhanvi Satija Oct 1 (Reuters) - The World Health Organization on Tuesday recommended vaccinating pregnant women and administering infants with an antibody to prevent severe respiratory synctial virus (RSV) infection in newborns.
A
G
P
S

WHO recommends maternal shot and antibody therapy to prevent RSV in infants

WHO recommends maternal shot and antibody therapy to prevent RSV in infants Oct 1 (Reuters) - The World Health Organization on Tuesday recommended maternal vaccination and the use of an antibody therapy to prevent respiratory synctial virus (RSV) in infants. The recommendations, to administer both the shot and the antibody or either, come after the WHO's strategic advisory group on immunization met last week.
A
G
P
S

ASM International, Burberry, LVMH

EUROPE RESEARCH ROUNDUP-ASM International, Burberry, LVMH Oct 1 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including ASM International, Burberry and LVMH on Tuesday. HIGHLIGHTS * ASM International ASMI.AS : Stifel cuts target price to EUR 740 from EUR 800 * Burberry Group BRBY.L : HSBC raises target price to 770p from 690p * Carlsberg CARLb.CO : Jefferies cuts target price to DKK 1,000 from DKK 1,100 * LVMH LVMH.PA : HSBC raises target p
A
A
A
A
A
B
B
G
G
G
H
H
H
H
K
K
L
L
M
P
P
R
S
V
A
B
B
I

Pfizer to sell about $3.25 bln stake in Sensodyne-maker Haleon, bookrunner says

UPDATE 3-Drug giant Pfizer sells $3.3 bln stake in Sensodyne-maker Haleon Placing at a 3.3% discount to Haleon's last close Haleon to buy back 230 mln stg worth of shares from Pfizer Pfizer to remain top Haleon shareholder -LSEG data Updates dateline to Oct. 1, recasts with final pricing, shares, other details throughout By Shanima A Oct 1 (Reuters) - Pfizer PFE.N sold a stake in British consumer healthcare group Haleon HLN.L worth about $3.26 billion on Monday, cutting its shareholding in the m
G
G
P

Sensodyne maker Haleon to raise stake in China JV

UPDATE 2-Sensodyne maker Haleon to raise stake in China JV To buy additional 33% stake for $637 mln Will have option to buy out remaining 12% stake Deal 'strategically and commercially' compelling -CEO Recasts, adds detail, background By Yadarisa Shabong Sept 27 (Reuters) - Haleon HLN.L plans to increase its stake in its Chinese joint venture to 88% from 55%, the British consumer healthcare company said on Friday.
A
G

GSK Gets Positive EU Opinion For Liquid Menveo Vaccine

BRIEF-GSK Gets Positive EU Opinion For Liquid Menveo Vaccine Sept 24 (Reuters) - GSK plc GSK.L : POSITIVE EU OPINION FOR GSK LIQUID MENVEO VACCINE MARKETING AUTHORISATION IN EU EXPECTED BY NOVEMBER 2024 Source text for Eikon: ID:nRSX2993Fa Further company coverage: GSK.L
G

Biogen-UCB's lupus drug meets main goal of late-stage trial

CORRECTED-Biogen-UCB's lupus drug meets main goal of late-stage trial Corrects executive's name to Meyers from Myers in paragraphs 5 and 6 By Manas Mishra Sept 24 (Reuters) - Biogen BIIB.O and Belgian partner UCB UCB.BR said on Tuesday their experimental lupus treatment met the main goal of a late-stage trial in patients with the chronic disease, a surprise result after the drug failed an earlier mid-stage study.
A
B
G
U

US FDA approves AstraZeneca's self-administered nasal spray flu vaccine

UPDATE 2-US FDA approves AstraZeneca's self-administered nasal spray flu vaccine Reworks lede, adds details on availability in paragraphs 4, details on the vaccine in paragraph 5, other vaccines in paragraph 9 Sept 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's AZN.L nasal spray flu vaccine for self-administration, making it the first of its kind.
A
G
S

Coca-Cola plans to invest $1 billion in Nigeria operations, presidency says

Coca-Cola plans to invest $1 billion in Nigeria operations, presidency says ABUJA, Sept 19 (Reuters) - Coca-Cola plans to invest $1 billion in its Nigeria operations over the next five years, the country's presidency said after a meeting between President Bola Tinubu and senior executives of the soft drinks maker on Thursday. Tinubu met John Murphy, president and chief financial officer of Coca‑Cola KO.N , Zoran Bogdanovic, CEO of Coca-Cola HBC CCH.L - one of Coca-Cola's many bottlers worldwid
B
G
C

Boehringer Ingelheim faces second hung jury in Chicago Zantac trial

UPDATE 1-Boehringer Ingelheim faces second hung jury in Chicago Zantac trial Hung jury in latest Zantac cancer trial in Chicago Boehringer Ingelheim only defendant after settlements with GSK, Pfizer FDA pulled Zantac in 2020 over NDMA carcinogen concerns Updates Sept 18 story with statement from Boehringer Ingelheim in paragraph 5 By Brendan Pierson Sept 18 (Reuters) - The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, as j
G
P
S

Boehringer Ingelheim faces second hung jury in Chicago Zantac trial

UPDATE 1-Boehringer Ingelheim faces second hung jury in Chicago Zantac trial Hung jury in latest Zantac cancer trial in Chicago Boehringer Ingelheim only defendant after settlements with GSK, Pfizer FDA pulled Zantac in 2020 over NDMA carcinogen concerns Updates Sept 18 story with statement from Boehringer Ingelheim in paragraph 5 By Brendan Pierson Sept 18 (Reuters) - The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, as j
G
P
S

A second Zantac cancer trial ends with hung jury

A second Zantac cancer trial ends with hung jury Hung jury in latest Zantac cancer trial in Chicago Boehringer Ingelheim only defendant after settlements with GSK, Pfizer FDA pulled Zantac in 2020 over NDMA carcinogen concerns By Brendan Pierson Sept 18 (Reuters) - The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, as jurors in Chicago were unable to agree on whether Boehringer Ingelheim must pay damages to an Illinois man
G
P
S

GSK settles two California lawsuits related to heartburn drug Zantac

UPDATE 1-GSK settles two California lawsuits related to heartburn drug Zantac Adds background and context Sept 18 (Reuters) - British drugmaker GSK GSK.L said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued heartburn drug Zantac caused cancer. GSK does not admit to any liability in either settlement, it said in a statement.
G
P
S

GSK's RSV, Shingles vaccines show on-par immune response in joint trial

UPDATE 1-GSK's RSV, Shingles vaccines show on-par immune response in joint trial Adds details on study in paragraph 2, company's statement in paragraph 4 Sept 18 (Reuters) - British drugmaker GSK GSK.L said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot together generated the same immune response in a late-stage trial as separate adminstration of the vaccines.
G

GSK's RSV vaccine meets main goal when co-administered with shingles shot

GSK's RSV vaccine meets main goal when co-administered with shingles shot Sept 18 (Reuters) - British drugmaker GSK GSK.L said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with its shingles shot, met the main goal of a late-stage trial in adults over 50 years of age. The company said co-administration of the vaccines generated an immune response that was at least on-par with separate administration.
G

Gsk Says Japan Accepts NDA For Blenrep In Multiple Myeloma

BRIEF-Gsk Says Japan Accepts NDA For Blenrep In Multiple Myeloma Sept 17 (Reuters) - GSK plc GSK.L : GSK PLC - JAPAN FILING ACCEPTANCE: BLENREP MULTIPLE MYELOMA Source text for Eikon: ID:nRSQ4071Ea Further company coverage: GSK.L
G

Iteos falls after mid-stage study results for lung cancer drug

BUZZ-Iteos falls after mid-stage study results for lung cancer drug Updates ** Shares of cancer drug developer Iteos Therapeutics ITOS.O slide 23.6% to $12.76 ** Stock had risen 27 .3% t o $21.26 in premarket trade ** Co says its lung cancer drug belrestotug, in combination with GSK's GSK.L drug dostarlimab, showed higher percentage of reduction or
G

Iteos rises on superior efficacy of lung cancer drug combo vs GSK’s Jemperli alone

BUZZ-Iteos rises on superior efficacy of lung cancer drug combo vs GSK’s Jemperli alone ** Shares of cancer drug developer Iteos Therapeutics ITOS.O rise 14.7% at $19.16 premarket ** Co says its lung cancer drug, belrestotug, in combination with GSK's GSK.L drug, dostarlimab, showed reduction or disappearance of tumor in 63.3%-76.7% patients, vs
G

Zenas BioPharma shares rise nearly 8% in market debut

UPDATE 2-Zenas BioPharma shares rise nearly 8% in market debut Adds details on U.S. IPO market in paragraph 4-5, details on the company from paragraph 6 onwards Sept 13 (Reuters) - Shares of Bristol-Myers Squibb-backed Zenas BioPharma ZBIO.O rose nearly 8% in their Nasdaq debut on Friday, a sign of recovery for the U.S. initial public offering market in 2024 after two subpar years.
C
G

GSK's Blenrep Receives Breakthrough Therapy Designation In China

BRIEF-GSK's Blenrep Receives Breakthrough Therapy Designation In China Sept 13 (Reuters) - GSK plc GSK.L : GSK PLC - CHINA BREAKTHROUGH THERAPY DESIGNATION FOR BLENREP GSK PLC - BLENREP RECEIVES BREAKTHROUGH THERAPY DESIGNATION IN CHINA Source text for Eikon: ID:nRSM0429Ea Further company coverage: GSK.L
G



商品详情

热门商品

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明